$ABBV Q3 2026 results are out.

By Nexqual Desk ·
Tickers: $ABBV
$ABBV Q3 2026 results are out.
EPS: $3.82 vs $3.77 est. (beat)
Revenue: $17.40B vs $17.35B est. (in line)
Outlook: AbbVie is increasing its full-year guidance.
Source: AbbVie earnings press release.
1 likes
Posted on Nexqual Sonar — the social network for the stock market. Not financial advice.